Cite

HARVARD Citation

    Banasavadi, Y. et al. (2021). DDRE-26. INHIBITION OF PRMT5 SENSITIZES GLIOBLASTOMA MODELS TO TRAMETINIB TREATMENT. Neuro-oncology. pp. vi79-vi80. [Online]. 
  
Back to record